- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
-
- MATSUBARA Makoto
- Department of Oral and Maxillofacial Surgery, Division of Oral Pathogenesis and Disease Control, Asahi University School of Dentistry
-
- SHIKIMORI Michio
- Department of Oral and Maxillofacial Surgery, Division of Oral Pathogenesis and Disease Control, Asahi University School of Dentistry
-
- FUJIMOTO Masako
- Department of Oral and Maxillofacial Surgery, Division of Oral Pathogenesis and Disease Control, Asahi University School of Dentistry
-
- OHTA Takahisa
- Department of Oral and Maxillofacial Surgery, Division of Oral Pathogenesis and Disease Control, Asahi University School of Dentistry
-
- TANAKA Shiro
- Department of Oral and Maxillofacial Surgery, Division of Oral Pathogenesis and Disease Control, Asahi University School of Dentistry
-
- SUMITOMO Shinichiro
- Department of Oral and Maxillofacial Surgery, Division of Oral Pathogenesis and Disease Control, Asahi University School of Dentistry
Bibliographic Information
- Other Title
-
- セビメリン塩酸塩水和物による口腔リンス法後の血中濃度の推移
- セビメリン エンサンエン スイワブツ ニ ヨル コウコウ リンスホウ ゴ ノ ケッチュウ ノウド ノ スイイ
Search this article
Description
Cevimeline hydrochloride hydrate (cevimeline) is used in the treatment of xerostomia associated with Sjogren's syndrome. However, this medication has muscarinic agonist activity and is associated with several adverse effects, including nausea, vomiting, and diarrhea. Oral rinsing with cevimeline is recommended to avoid these adverse effects, but cevimeline blood concentration after rinsing has not been thoroughly investigated. This study measured blood cevimeline concentration after oral rinsing at a concentration of 30 mg in 50 ml of water and determined that the maximum plasma concentration of 4.04 ± 1.10 ng/ml occurred two hours later, which is longer than the time to maximum concentration after an oral administration of 30 mg. Furthermore, the maximum concentration after rinsing was 5.5% of the maximum concentration after oral administration, and the half-life after rinsing was 6 hours, which is longer than the half-life after oral administration.
Journal
-
- Journal of The Japanese Stomatological Society
-
Journal of The Japanese Stomatological Society 62 (1), 1-4, 2013
Japanese Stomatological Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390282681412723712
-
- NII Article ID
- 130004555777
- 40019657415
-
- NII Book ID
- AN00189050
-
- ISSN
- 21850461
- 00290297
-
- NDL BIB ID
- 024576065
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL Search
- CiNii Articles
-
- Abstract License Flag
- Disallowed